Literature DB >> 27624840

The emerging role of obesity, diet and lipid metabolism in prostate cancer.

Matteo Ferro1, Daniela Terracciano2, Carlo Buonerba3, Giuseppe Lucarelli4, Danilo Bottero1, Sisto Perdonà5, Riccardo Autorino6, Alessandro Serino1, Francesco Cantiello7, Rocco Damiano7, Iulia Andras8, Sabino De Placido3, Giuseppe Di Lorenzo3, Michele Battaglia4, Barbara A Jereczek-Fossa9,10, Vincenzo Mirone11, Ottavio De Cobelli1,8,12.   

Abstract

Obesity is associated with an increased risk of a number of serious medical conditions, including cancer. As far as prostate cancer is concerned, obesity is associated with an increased risk of high-grade tumors, which is possibly related to lower androgen levels. Diet may also affect prostate cancer risk since countries with a higher dietary fat intake also present higher prostate cancer mortality rates. Interestingly, prostate cancer is associated with a number of metabolic alterations that may provide valuable diagnostic and therapeutic targets. This review explores the available clinical as well as biological evidence supporting the relationship between obesity, diet, alteration in metabolic pathways and prostate cancer.

Entities:  

Keywords:  diet; obesity; urologic/prostate

Mesh：

Year:  2016        PMID： 27624840      PMCID： PMC5619099          DOI： 10.2217/fon-2016-0217

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


  86 in total

Review 1.  International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease.

Authors:  Cristina Magi-Galluzzi; Andrew J Evans; Brett Delahunt; Jonathan I Epstein; David F Griffiths; Theo H van der Kwast; Rodolfo Montironi; Thomas M Wheeler; John R Srigley; Lars L Egevad; Peter A Humphrey
Journal:  Mod Pathol       Date:  2010-08-27       Impact factor: 7.842

2.  Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis.

Authors:  S F Shariat; B Andrews; M W Kattan; J Kim; T M Wheeler; K M Slawin
Journal:  Urology       Date:  2001-12       Impact factor: 2.649

3.  Total testosterone levels are correlated to metabolic syndrome components.

Authors:  Rodrigo Blaya; Leonardo Dalla Giacomassa Rocha Thomaz; Fernanda Guilhermano; Artur de Oliveira Paludo; Luiza Rhoden; Graziele Halmenschlager; Ernani Luis Rhoden
Journal:  Aging Male       Date:  2016-03-09       Impact factor: 5.892

4.  Tumor cell-educated periprostatic adipose tissue acquires an aggressive cancer-promoting secretory profile.

Authors:  Ricardo J T Ribeiro; Cátia P D Monteiro; Virginia F P M Cunha; Andreia S M Azevedo; Maria J Oliveira; Rosário Monteiro; Avelino M Fraga; Paulo Príncipe; Carlos Lobato; Francisco Lobo; António Morais; Vitor Silva; José Sanches-Magalhães; Jorge Oliveira; João T Guimarães; Carlos M S Lopes; Rui M Medeiros
Journal:  Cell Physiol Biochem       Date:  2012-03-01

Review 5.  The AMPK-FoxO3A axis as a target for cancer treatment.

Authors:  Fulvio Chiacchiera; Cristiano Simone
Journal:  Cell Cycle       Date:  2010-03-15       Impact factor: 4.534

6.  Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy.

Authors:  Shahrokh F Shariat; Veronica A Anwuri; Dolores J Lamb; Nina V Shah; Thomas M Wheeler; Kevin M Slawin
Journal:  J Clin Oncol       Date:  2004-05-01       Impact factor: 44.544

Review 7.  Obesity and prostate cancer: epidemiology and clinical implications.

Authors:  W Cooper Buschemeyer; Stephen J Freedland
Journal:  Eur Urol       Date:  2007-05-02       Impact factor: 20.096

8.  Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors.

Authors:  Elahe A Mostaghel; Keith R Solomon; Kristine Pelton; Michael R Freeman; R Bruce Montgomery
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240

Review 9.  The role of dietary fat throughout the prostate cancer trajectory.

Authors:  Katie M Di Sebastiano; Marina Mourtzakis
Journal:  Nutrients       Date:  2014-12-22       Impact factor: 5.717

10.  Prostate cancer cell proliferation is influenced by leptin.

Authors:  Ponnandai Somasundar; Krista A Frankenberry; Heath Skinner; Giridhar Vedula; David W McFadden; Dale Riggs; Barbara Jackson; Reyna Vangilder; Stanley M Hileman; Linda C Vona-Davis
Journal:  J Surg Res       Date:  2004-05-01       Impact factor: 2.192
View more
  26 in total

Review 1.  Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.

Authors:  Lisa M Butler; Ylenia Perone; Jonas Dehairs; Leslie E Lupien; Vincent de Laat; Ali Talebi; Massimo Loda; William B Kinlaw; Johannes V Swinnen
Journal:  Adv Drug Deliv Rev       Date:  2020-07-23       Impact factor: 15.470

2.  Obesity influence on bladder inflammation and cancer: a cystitis model.

Authors:  Cristiano Trindade de Andrade; Guilherme Zweig Rocha; Marina Zamuner; Rodolfo Borges Dos Reis; Leonardo Oliveira Reis
Journal:  Int J Clin Exp Pathol       Date:  2022-09-15

3.  The Influence of Prednisone on the Efficacy of Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer.

Authors:  Carlo Buonerba; Guru Sonpavde; Francesca Vitrone; Davide Bosso; Livio Puglia; Michela Izzo; Simona Iaccarino; Luca Scafuri; Margherita Muratore; Francesca Foschini; Brigitta Mucci; Vincenzo Tortora; Martina Pagliuca; Dario Ribera; Vittorio Riccio; Rocco Morra; Mirta Mosca; Nicola Cesarano; Ileana Di Costanzo; Sabino De Placido; Giuseppe Di Lorenzo
Journal:  J Cancer       Date:  2017-08-22       Impact factor: 4.207

4.  Obesity and metabolic dysfunction severely influence prostate cell function: role of insulin and IGF1.

Authors:  Fernando L-López; André Sarmento-Cabral; Vicente Herrero-Aguayo; Manuel D Gahete; Justo P Castaño; Raúl M Luque
Journal:  J Cell Mol Med       Date:  2017-02-28       Impact factor: 5.310

Review 5.  Exercise-induced myokines and their effect on prostate cancer.

Authors:  Jin-Soo Kim; Daniel A Galvão; Robert U Newton; Elin Gray; Dennis R Taaffe
Journal:  Nat Rev Urol       Date:  2021-06-22       Impact factor: 14.432

6.  BMI and serum lipid parameters predict increasing risk and aggressive prostate cancer in Chinese people.

Authors:  Ruizhe Zhao; Gong Cheng; Bing Wang; Chao Qin; Yun Liu; Yongsheng Pan; Jun Wang; Lixin Hua; Weidong Zhu; Zengjun Wang
Journal:  Oncotarget       Date:  2017-08-02

Review 7.  Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease.

Authors:  Reuben L Smith; Maarten R Soeters; Rob C I Wüst; Riekelt H Houtkooper
Journal:  Endocr Rev       Date:  2018-08-01       Impact factor: 19.871

8.  Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy.

Authors:  Vincenzo Serretta; Alberto Abrate; Simone Siracusano; Cristina Scalici Gesolfo; Marco Vella; Fabrizio Di Maida; Antonina Cangemi; Giuseppe Cicero; Elisabetta Barresi; Chiara Sanfilippo
Journal:  Urol Ann       Date:  2018 Jul-Sep

9.  Process Optimization for Improved Phenolic Compounds Recovery from Walnut (Juglans regia L.) Septum: Phytochemical Profile and Biological Activities.

Authors:  Marius Emil Rusu; Ana-Maria Gheldiu; Andrei Mocan; Cadmiel Moldovan; Daniela-Saveta Popa; Ioan Tomuta; Laurian Vlase
Journal:  Molecules       Date:  2018-10-30       Impact factor: 4.411

10.  Diosmetin suppresses human prostate cancer cell proliferation through the induction of apoptosis and cell cycle arrest.

Authors:  Christine Oak; Ahmad O Khalifa; Ilaha Isali; Natarajan Bhaskaran; Ethan Walker; Sanjeev Shukla
Journal:  Int J Oncol       Date:  2018-05-16       Impact factor: 5.650
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.